Analysts expect Prelude Therapeutics Inc to report revenue of 25.86 M for Q3 26, against a range of 24.75 M to 26.97 M. The most recent reported quarter, Q2 26, came in at 5.70 M.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 3.00 M | 4.00 M | 0.00 | 0.00 | 6.50 M | 5.60 M | 4.58 M | 5.70 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 22.08 M | 0.00 | 0.00 | 26.97 M | 2.66 M | 5.01 M | 6.18 M | 31.34 M | 10.70 M | 17.28 M | 19.50 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 19.84 M | 0.00 | 0.00 | 24.75 M | 2.34 M | 4.70 M | 5.33 M | 26.68 M | 9.12 M | 15.11 M | 16.15 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.96 M | 0.00 | 0.00 | 25.86 M | 2.50 M | 4.85 M | 5.76 M | 29.01 M | 9.91 M | 16.20 M | 17.83 M |
Analysts expect Prelude Therapeutics Inc to report earnings per share of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at -0.14, a 33.3% beat against the -0.21 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.43 | -0.37 | -0.42 | -0.41 | -0.26 | -0.20 | -0.13 | -0.14 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.46 | -0.40 | -0.43 | -0.38 | -0.33 | -0.03 | -0.23 | -0.20 | 0.00 | -0.15 | -0.15 | -0.14 | 0.04 | -0.06 | -0.09 | -0.09 | ||||||||||
| Low Estimate | -0.52 | -0.46 | -0.53 | -0.46 | -0.37 | -0.03 | -0.29 | -0.22 | 0.00 | -0.17 | -0.17 | -0.16 | 0.04 | -0.08 | -0.11 | -0.11 | ||||||||||
| Consensus Estimate | -0.49 | -0.43 | -0.48 | -0.42 | -0.35 | -0.03 | -0.26 | -0.21 | 0.00 | -0.16 | -0.16 | -0.15 | 0.04 | -0.07 | -0.10 | -0.10 |
Pull Wall Street consensus for Prelude Therapeutics Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=PRLD&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "PRLD", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=PRLD&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();